140 related articles for article (PubMed ID: 11452166)
1. Role of oral versus IV iron supplementation in the erythropoietic response to rHuEPO: a randomized, placebo-controlled trial.
Olijhoek G; Megens JG; Musto P; Nogarin L; Gassmann-Mayer C; Vercammen E; Hayes-Licitra SA
Transfusion; 2001 Jul; 41(7):957-63. PubMed ID: 11452166
[TBL] [Abstract][Full Text] [Related]
2. Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. A randomized, controlled trial.
Feagan BG; Wong CJ; Kirkley A; Johnston DW; Smith FC; Whitsitt P; Wheeler SL; Lau CY
Ann Intern Med; 2000 Dec; 133(11):845-54. PubMed ID: 11103054
[TBL] [Abstract][Full Text] [Related]
3. Autologous blood donation plus epoetin alfa in nonanemic orthopedic surgery patients.
Baudoux E
Semin Hematol; 1996 Apr; 33(2 Suppl 2):31-2; discussion 33. PubMed ID: 8723579
[TBL] [Abstract][Full Text] [Related]
4. Epoetin alfa plus autologous blood donation and normovolemic hemodilution in patients scheduled for orthopedic or vascular surgery.
Tryba M
Semin Hematol; 1996 Apr; 33(2 Suppl 2):34-6; discussion 37-8. PubMed ID: 8723580
[TBL] [Abstract][Full Text] [Related]
5. Intravenous ferric gluconate significantly improves response to epoetin alfa versus oral iron or no iron in anemic patients with cancer receiving chemotherapy.
Henry DH; Dahl NV; Auerbach M; Tchekmedyian S; Laufman LR
Oncologist; 2007 Feb; 12(2):231-42. PubMed ID: 17296819
[TBL] [Abstract][Full Text] [Related]
6. Pharmacokinetics and pharmacodynamics of once-weekly subcutaneous epoetin alfa in critically ill patients: results of a randomized, double-blind, placebo-controlled trial.
Vincent JL; Spapen HD; Creteur J; Piagnerelli M; Hubloue I; Diltoer M; Roman A; Stevens E; Vercammen E; Beaver JS
Crit Care Med; 2006 Jun; 34(6):1661-7. PubMed ID: 16607233
[TBL] [Abstract][Full Text] [Related]
7. Pharmacokinetics and pharmacodynamics of recombinant human erythropoietin after single and multiple subcutaneous doses to healthy subjects.
Cheung WK; Goon BL; Guilfoyle MC; Wacholtz MC
Clin Pharmacol Ther; 1998 Oct; 64(4):412-23. PubMed ID: 9797798
[TBL] [Abstract][Full Text] [Related]
8. Enhanced efficacy of autologous blood donation with epoetin alfa.
Nydegger U
Semin Hematol; 1996 Apr; 33(2 Suppl 2):39-40; discussion 41-2. PubMed ID: 8723581
[TBL] [Abstract][Full Text] [Related]
9. Perisurgical use of epoetin alfa in orthopedic surgery patients.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):55-8; discussion 59. PubMed ID: 8723584
[TBL] [Abstract][Full Text] [Related]
10. Preoperative Epoetin-α with Intravenous or Oral Iron for Major Orthopedic Surgery: A Randomized Controlled Trial.
Biboulet P; Bringuier S; Smilevitch P; Loupec T; Thuile C; Pencole M; Maissiat G; Dangelser G; Capdevila X
Anesthesiology; 2018 Oct; 129(4):710-720. PubMed ID: 30074935
[TBL] [Abstract][Full Text] [Related]
11. Epoetin alfa in low hematocrit patients to facilitate autologous blood donation in total hip replacement: a randomized, double-blind, placebo-controlled, dose-ranging study.
Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Oriani G
Acta Haematol; 1998; 100(2):69-76. PubMed ID: 9792935
[TBL] [Abstract][Full Text] [Related]
12. Epoetin alfa increases the volume of autologous blood donated by patients scheduled to undergo orthopedic surgery.
Mercuriali F
Semin Hematol; 1996 Apr; 33(2 Suppl 2):10-2; discussion 13-4. PubMed ID: 8723574
[TBL] [Abstract][Full Text] [Related]
13. Epoetin alfa for autologous blood donation in patients with rheumatoid arthritis and concomitant anemia.
Mercuriali F
Semin Hematol; 1996 Apr; 33(2 Suppl 2):18-20; discussion 21. PubMed ID: 8723576
[TBL] [Abstract][Full Text] [Related]
14. Comparison between intravenous and subcutaneous recombinant human erythropoietin (Epoetin alfa) administration in presurgical autologous blood donation in anemic rheumatoid arthritis patients undergoing major orthopedic surgery.
Mercuriali F; Inghilleri G; Biffi E; Colotti MT; Vinci A; Sinigaglia L; Gualtieri G
Vox Sang; 1997; 72(2):93-100. PubMed ID: 9088076
[TBL] [Abstract][Full Text] [Related]
15. Use of epoetin alfa in autologous blood donation programs for patients scheduled for elective cardiac surgery.
Walpoth B; Galliker B; Spirig P; Haeberli A; Rosenmund A; Althaus U; Nydegger UE
Semin Hematol; 1996 Apr; 33(2 Suppl 2):75-6; discussion 77. PubMed ID: 8723588
[TBL] [Abstract][Full Text] [Related]
16. A new dose-intense epoetin alfa regimen effective in anemic cancer patients receiving chemotherapy: an open-label, non randomized, pilot study.
Santini D; Vincenzi B; La Cesa A; Virzi V; Navajas F; Malafarina V; Dicuonzo G; Cassandro R; Esposito V; Montesarchio V; Groeger AM; Tonini G
Anticancer Res; 2005; 25(1B):669-74. PubMed ID: 15816644
[TBL] [Abstract][Full Text] [Related]
17. The estimation of efficacy of oral iron supplementation during treatment with epoetin beta (recombinant human erythropoietin) in patients undergoing cardiac surgery.
Sowade O; Messinger D; Franke W; Sowade B; Scigalla P; Warnke H
Eur J Haematol; 1998 Apr; 60(4):252-9. PubMed ID: 9579879
[TBL] [Abstract][Full Text] [Related]
18. Kinetics of reticulocyte maturity fractions and indices and iron status during therapy with epoetin beta (recombinant human erythropoietin) in cardiac surgery patients.
Sowade O; Sowade B; Brilla K; Franke W; Stephan P; Gross J; Scigalla P; Warnke H
Am J Hematol; 1997 Jun; 55(2):89-96. PubMed ID: 9209004
[TBL] [Abstract][Full Text] [Related]
19. EORTC guidelines for the use of erythropoietic proteins in anaemic patients with cancer: 2006 update.
Bokemeyer C; Aapro MS; Courdi A; Foubert J; Link H; Osterborg A; Repetto L; Soubeyran P;
Eur J Cancer; 2007 Jan; 43(2):258-70. PubMed ID: 17182241
[TBL] [Abstract][Full Text] [Related]
20. Erythropoietin, iron metabolism, and red blood cell production.
Adamson J
Semin Hematol; 1996 Apr; 33(2 Suppl 2):5-7; discussion 8-9. PubMed ID: 8723573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
